Association between the c.1161G>A and c.1779C>G genetic variants of XRCC1 gene and hepatocellular carcinoma risk in Chinese population

International Journal of Biological Sciences

Volumn 9, Issue 3, 2013, Pages 289-294

  Deng, Xin ^a   Liang, Jian ^a   Jiang, Majun ^a   Zhou, Xiaoxiao ^a   Liu, Hongdan ^a  

^a RUIKANG HOSPITAL AFFILIATED TO GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Genetic variants; Hepatocellular carcinoma; Molecular markers; Risk factors; Susceptibility; XRCC1 gene

Indexed keywords

DNA BINDING PROTEIN; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1; XRCC1 PROTEIN;

ARTICLE; CHINA; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENETIC VARIANTS; GENETICS; GENOTYPE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MOLECULAR MARKERS; RISK FACTOR; RISK FACTORS.; SUSCEPTIBILITY; XRCC1 GENE;

GENETIC VARIANTS; HEPATOCELLULAR CARCINOMA; MOLECULAR MARKERS; RISK FACTORS.; SUSCEPTIBILITY; XRCC1 GENE;

CARCINOMA, HEPATOCELLULAR; CHINA; DNA-BINDING PROTEINS; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; GENOTYPE; HUMANS; LIVER NEOPLASMS; RISK FACTORS;

EID: 84874986109     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.5928     Document Type: Article

References (32)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108.
2. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362(9399):1907-1917.
3. Parikh S, Hyman D. Hepatocellular cancer: a guide for the internist. Am J Med. 2007;120(3):194-202.
4. But DY, Lai CL, Yuen MF. Natural history of hepatitis-related hepatocellular carcinoma. World J Gastroenterol. 2008;14(11):1652-1656.
5. Yuen MF, Hou JL, Chutaputti A. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol. 2009;24(3):346-353.
6. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2(9):533-543.
7. Schutte K, Bornschein J, Malfertheiner P. Hepatocellular carcinoma--epidemiological trends and risk factors. Dig Dis. 2009;27(2):80-92.
8. Chen JG, Zhang SW, Chen WQ. [Analysis of liver cancer mortality in the national retrospective sampling survey of death causes in China, 2004 2005]. Zhonghua Yu Fang Yi Xue Za Zhi. 2010;44(5):383-389.
9. Rossit AR, Cabral IR, Hackel C, et al. Polymorphisms in the DNA repair gene XRCC1 and susceptibility to alcoholic liver cirrhosis in older Southeastern Brazilians. Cancer Lett. 2002;180(2):173-182.
10. Yu MW, Yang SY, Pan IJ, et al. Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst. 2003;95(19):1485-1488.
11. Kiran M, Chawla YK, Jain M, et al. Haplotypes of microsomal epoxide hydrolase and x-ray cross-complementing group 1 genes in Indian hepatocellular carcinoma patients. DNA Cell Biol. 2009;28(11):573-577.
12. Kiran M, Saxena R, Chawla YK, et al. Polymorphism of DNA repair gene XRCC1 and hepatitis-related hepatocellular carcinoma risk in Indian population. Mol Cell Biochem. 2009;327(1-2):7-13.
13. Pan HZ, Liang J, Yu Z, et al. Polymorphism of DNA repair gene XRCC1 and hepatocellular carcinoma risk in Chinese population. Asian Pac J Cancer Prev. 2011;12(11):2947-2950.
14. Li QW, Lu CR, Ye M, et al. Evaluation of DNA repair gene XRCC1 polymorphism in prediction and prognosis of hepatocellular carcinoma risk. Asian Pac J Cancer Prev. 2012;13(1):191-194.
15. Han X, Xing Q, Li Y, et al. Study on the DNA Repair Gene XRCC1 and XRCC3 Polymorphism in Prediction and Prognosis of Hepatocellular Carcinoma Risk. Hepatogastroenterology. 2012; epub.
16. Long XD, Ma Y, Huang HD, et al. Polymorphism of XRCC1 and the frequency of mutation in codon 249 of the p53 gene in hepatocellular carcinoma among Guangxi population, China. Mol Carcinog. 2008;47(4):295-300.
17. Liu F, Li B, Wei Y, et al. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis. Liver Int. 2011;31(6):802-809.
18. Borentain P, Gerolami V, Ananian P, et al. DNA-repair and carcinogen-metabolising enzymes genetic polymorphisms as an independent risk factor for hepatocellular carcinoma in Caucasian liver-transplanted patients. Eur J Cancer. 2007;43(17):2479-2486.
19. Long XD, Ma Y, Wei YP, et al. The polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China. Hepatol Res. 2006;36(1):48-55.
20. Chen CC, Yang SY, Liu CJ, et al. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Int J Epidemiol. 2005;34(6):1310-1318.
21. Kirk GD, Turner PC, Gong Y, et al. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity. Cancer Epidemiol Biomarkers Prev. 2005;14(2):373-379.
22. Daly AK, Steen VM, Fairbrother KS, et al. CYP2D6 multiallelism. Methods Enzymol. 1996;272:199-210.
23. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6(9):674-687.
24. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557-2576.
25. Amarapurkar DN, Patel ND, Kamani PM. Impact of diabetes mellitus on outcome of HCC. Ann Hepatol. 2008;7(2):148-151.
26. Marrero JA, Fontana RJ, Fu S, et al. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol. 2005;42(2):218-224.
27. Yu L, Sun L, Jiang YF, et al. Interactions between CYP1A1 polymorphisms and cigarette smoking are associated with the risk of hepatocellular carcinoma: evidence from epidemiological studies. Mol Biol Rep. 2012;39(6):6641-6646.
28. Nault JC, Zucman-Rossi J. Genetics of hepatobiliary carcinogenesis. Semin Liver Dis. 2011;31(2):173-187.
29. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 2002;31(4):339-346.
30. Bayram S, Akkiz H, Bekar A, et al. The significance of Exonuclease 1 K589E polymorphism on hepatocellular carcinoma susceptibility in the Turkish population: a case-control study. Mol Biol Rep. 2012;39(5):5943-5951.
31. Sumbul AT, Akkiz H, Bayram S, et al. p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study. Mol Biol Rep. 2012;39(2):1639-1647.
32. Ning S, Bin C, Na H, et al. Glypican-3, a novel prognostic marker of hepatocellular cancer, is related with postoperative metastasis and recurrence in hepatocellular cancer patients. Mol Biol Rep. 2012;39(1):351-357.